Peculiarities of Adverse Events Manifested by Injury of Skin and Skin Derivatives and Associated with Beta-blockers Use

More than 50 years after Propranolol was introduced to the pharmaceutical market as a drug that can lower the heart rate, beta-blockers (BAB) are still widely used in the pharmacotherapy of cardiovascular diseases. However, the use of BAB has a number of limitations, first of all, due to adverse dru...

Full description

Bibliographic Details
Main Authors: A. V. Matveev, E. A. Egorova, E. I. Konyaeva, A. G. Dormidor, E. Yu. Bekirova
Format: Article
Language:English
Published: Столичная издательская компания 2021-11-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:https://www.rpcardio.online/jour/article/view/2591